Tracksun Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 21-05-2024
- Paid Up Capital ₹ 0.50 M
as on 21-05-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Tracksun Pharmaceutical
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Swati Bagla, Jyoti Verma, Sanjay Kumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999DL2017PLC311554
- Company No.
311554
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tracksun Pharmaceutical?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swati Bagla  | Director | 15-Feb-2018 | Current |
| Jyoti Verma | Director | 13-Feb-2017 | Current |
| Sanjay Kumar | Director | 06-Feb-2017 | Current |
| Arvind Kumar | Director | 13-Feb-2017 | Current |
| Ashish Kumar | Director | 06-Feb-2017 | Current |
Financial Performance and Corporate Structure Insights of Tracksun Pharmaceutical.
Tracksun Pharmaceutical Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tracksun Pharmaceutical?
In 2017, Tracksun Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tracksun Batteries Private Limited
Active
7 years 11 months Jyoti Verma, Sanjay Kumar and 1 more are mutual person
Tracksun Solar Private Limited
Active 11 years 5 months Arvind Kumar and Ashish Kumar are mutual person
Gharonda Projects Private Limited
Active 22 years 5 months Arvind Kumar and Ashish Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tracksun Pharmaceutical?
Unlock and access historical data on people associated with Tracksun Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tracksun Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tracksun Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
